Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$349,139,950
-$301,941,171 QoQ
Shares Held
6,660,434
-43.5% QoQ
Ownership
0.333%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#10
of 1,033 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. GSK ranks #6 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
This page
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in GSK
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $349,139,950 | 6,660,434 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $651,081,121 | 11,797,085 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $439,602,357 | 8,964,159 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $120,349,847 | 2,788,458 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $108,470,208 | 2,824,745 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $154,275,231 | 3,982,324 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $44,610,406 | 1,319,054 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $166,225,724 | 4,066,187 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $65,844,702 | 1,710,252 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $95,162,740 | 2,219,798 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $29,383,502 | 792,863 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $48,739,248 | 1,344,531 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $149,944,608 | 4,207,200 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $175,882,151 | 4,943,287 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $230,364,908 | 6,555,632 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $191,641,155 | 6,511,762 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $458,119,867 | 10,730,254 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $145,260,958 | 3,400,013 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $77,341,795 | 1,788,114 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $11,528,555 | 307,622 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,912,401 | 202,594 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $56,833,260 | 1,623,587 | Shares | Defined | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||